GAFA
MDT icon

Garton & Associates Financial Advisors’s Medtronic MDT Stock Holding History

Garton & Associates Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,056
Closed -$958K – 45
2026
Q1 		$958K Buy
11,056
+6,306
+133% +$604K 0.78% 40
2025
Q4 		$456K Buy
+4,750
New +$461K 0.26% 71

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Garton & Associates Financial Advisors's MDT Position: Q2 2026 in Review

Garton & Associates Financial Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 11,056 shares — an estimated $958K sold.

Garton & Associates Financial Advisors first reported a position in MDT in Q4 2025 and held it in 2 quarters. The position peaked at $958K in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Garton & Associates Financial Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 11,056 Medtronic shares in Q2 2026, an estimated $958K.
  • Garton & Associates Financial Advisors first reported a position in Medtronic in Q4 2025 and held it in 2 quarters.
  • Garton & Associates Financial Advisors's Medtronic position peaked at $958K in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.